| Embracing diversity: macrophage complexity in cancer J Hochstadt, SM Pacheco, M Casanova-Acebes Trends in Cancer, 2025 | | 2025 |
| AXL pathway as a target to overcome resistance to PARP inhibitors in high-grade serous ovarian (HGSOC) and triple-negative breast cancer (TNBC) cell lines. JA Perez-Fidalgo, JJ Martinez Pretel, P Sanchez Serrano, V Heredia, ... Journal of Clinical Oncology 41 (16_suppl), e17502-e17502, 2023 | | 2023 |
| 585P Trabectedin induces apoptosis regardless of acquired resistance to PARP inhibitors in BRCA2 mutant high grade ovarian cancer cell lines JAP Fidalgo, P Sanchez-Serrano, V Heredia, JJM Pretel, J Hochstadt, ... Annals of Oncology 33, S814, 2022 | | 2022 |
| 583P Aurora kinase overexpression may play a role in PARPi resistance in tumor samples of patients with high grade ovarian cancer and its inhibition with alisertib overcomes … JAP Fidalgo, JJM Pretel, V Heredia, MR Marin, M Mendiola, J Hochstadt, ... Annals of Oncology 33, S813-S814, 2022 | | 2022 |
| 18P In vitro analysis of the combination of APR-246 and carboplatin in triple negative breast cancer (TNBC) and high grade serous ovarian cancer (HGSOC) cell lines and its … JJ Martinez-Pretel, B Pineda, K Eguez, BO Morillo, J Hochstadt, ... Annals of Oncology 32, S366, 2021 | | 2021 |
